Abstract
To the Editor, Benign Prostatic Hyperplasia (BPH) is one of the main causes of patients seeking urological counselling in Western countries. It has been estimated that nearly 70 percent of United States men between the ages of 60 and 69 years, and nearly 80 percent of men ≥ 70 years, have some degree of BPH [...].
Publication types
-
Randomized Controlled Trial
MeSH terms
-
Adrenergic alpha-Antagonists / therapeutic use
-
Aged
-
Electromagnetic Phenomena
-
Humans
-
Male
-
Middle Aged
-
Prostatic Hyperplasia* / complications
-
Urinary Bladder Neck Obstruction* / drug therapy
-
Urinary Bladder Neck Obstruction* / etiology
Substances
-
Adrenergic alpha-Antagonists